|
Volumn 56, Issue 2, 2010, Pages 39-100
|
Cerebral vascular disease.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
FIBRINOLYTIC AGENT;
ACUTE DISEASE;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
DIABETES MELLITUS;
EVIDENCE BASED PRACTICE;
FEMALE;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
LIFESTYLE;
MALE;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIMARY HEALTH CARE;
PRIMARY PREVENTION;
RECURRENT DISEASE;
REVIEW;
RISK FACTOR;
SMOKING;
STROKE;
UNITED STATES;
ACUTE DISEASE;
BRAIN ISCHEMIA;
CEREBRAL HEMORRHAGE;
DIABETES COMPLICATIONS;
EVIDENCE-BASED PRACTICE;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
HYPERLIPIDEMIAS;
HYPERTENSION;
LIFE STYLE;
MALE;
PATIENT CARE TEAM;
PLATELET AGGREGATION INHIBITORS;
PRACTICE GUIDELINES AS TOPIC;
PRIMARY HEALTH CARE;
PRIMARY PREVENTION;
RECURRENCE;
RISK FACTORS;
SMOKING;
STROKE;
UNITED STATES;
|
EID: 77649220795
PISSN: None
EISSN: 15578194
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (181)
|